Ignacio Esteban

1.4k total citations
14 papers, 259 citations indexed

About

Ignacio Esteban is a scholar working on Epidemiology, Infectious Diseases and Neurology. According to data from OpenAlex, Ignacio Esteban has authored 14 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Infectious Diseases and 3 papers in Neurology. Recurrent topics in Ignacio Esteban's work include Respiratory viral infections research (4 papers), Pneumonia and Respiratory Infections (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Ignacio Esteban is often cited by papers focused on Respiratory viral infections research (4 papers), Pneumonia and Respiratory Infections (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Ignacio Esteban collaborates with scholars based in Argentina, United States and Switzerland. Ignacio Esteban's co-authors include M Vilardell, Luis Garegnani, Juan Víctor Ariel Franco, Camila Micaela Escobar Liquitay, J. Bosch, Roser Solans, Josep Ordi‐Ros, Sílvia Sauleda, Fernando P. Polack and Renato T. Stein and has published in prestigious journals such as Cochrane Database of Systematic Reviews, Vaccines and Jornal Brasileiro de Pneumologia.

In The Last Decade

Ignacio Esteban

11 papers receiving 252 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignacio Esteban Argentina 5 158 79 74 45 40 14 259
Benjamín López France 11 107 0.7× 68 0.9× 25 0.3× 19 0.4× 6 0.1× 25 240
Christos Koutsianas Greece 8 92 0.6× 21 0.3× 77 1.0× 47 1.0× 53 1.3× 32 206
Christian Folli Italy 7 100 0.6× 53 0.7× 13 0.2× 30 0.7× 31 0.8× 14 275
Alessio Fabbrizzi Italy 9 133 0.8× 90 1.1× 91 1.2× 17 0.4× 200 5.0× 12 336
Philip Ginsburg United States 9 140 0.9× 24 0.3× 71 1.0× 44 1.0× 30 0.8× 17 337
F. Zhang China 8 68 0.4× 28 0.4× 88 1.2× 108 2.4× 7 0.2× 23 275
M.G. Ercilla Spain 10 161 1.0× 25 0.3× 151 2.0× 28 0.6× 158 4.0× 19 397
Carmen Hidalgo Spain 7 51 0.3× 30 0.4× 135 1.8× 34 0.8× 9 0.2× 18 301
Akiko Fujiwara Japan 10 144 0.9× 52 0.7× 14 0.2× 13 0.3× 124 3.1× 28 320
Shiva Prasad India 10 54 0.3× 19 0.2× 105 1.4× 49 1.1× 8 0.2× 22 263

Countries citing papers authored by Ignacio Esteban

Since Specialization
Citations

This map shows the geographic impact of Ignacio Esteban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Esteban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Esteban more than expected).

Fields of papers citing papers by Ignacio Esteban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Esteban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Esteban. The network helps show where Ignacio Esteban may publish in the future.

Co-authorship network of co-authors of Ignacio Esteban

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Esteban. A scholar is included among the top collaborators of Ignacio Esteban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Esteban. Ignacio Esteban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Garegnani, Luis, et al.. (2025). Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database of Systematic Reviews. 2025(7). CD013757–CD013757. 2 indexed citations
3.
4.
Esteban, Ignacio, Juliana Carvalho Ferreira, & Cecília Maria Patino. (2022). Why is conducting pragmatic clinical trials so important?. Jornal Brasileiro de Pneumologia. 48(5). e20220397–e20220397.
5.
Garegnani, Luis, et al.. (2021). Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children. Cochrane Database of Systematic Reviews. 2021(11). CD013757–CD013757. 110 indexed citations
6.
7.
Esteban, Ignacio, Melissa Bronstein, Vincent E. Ziegler, et al.. (2021). Asymptomatic COVID-19 in the Elderly: Dementia and Viral Clearance as Risk Factors for Disease Progression. A3826–A3826. 1 indexed citations
8.
Esteban, Ignacio, Renato T. Stein, & Fernando P. Polack. (2020). A Durable Relationship: Respiratory Syncytial Virus Bronchiolitis and Asthma past Their Golden Anniversary. Vaccines. 8(2). 201–201. 19 indexed citations
9.
Garegnani, Luis, et al.. (2020). Palivizumab for preventing respiratory syncytial virus (RSV) infection in children. Cochrane Database of Systematic Reviews. 3 indexed citations
10.
Esteban, Ignacio, et al.. (2019). Neumonía bullosa secundaria a Elizabethkingia meningoseptica, su evolución clínica y radiológica. Archivos Argentinos de Pediatria. 117(2). e150–e154. 2 indexed citations
11.
Esteban, Ignacio, et al.. (2016). Histoplasmosis en el sistema nervioso central en una paciente pediátrica inmunocompetente. Archivos Argentinos de Pediatria. 114(3). e171–4. 4 indexed citations
12.
Solans, Roser, J. Bosch, Ignacio Esteban, & M Vilardell. (2004). Systemic sclerosis developing in association with the use of interferon alpha therapy for chronic viral hepatitis.. PubMed. 22(5). 625–8. 46 indexed citations
13.
Ordi‐Ros, Josep, et al.. (2000). Anticardiolipin Antibodies in Patients with Chronic Hepatitis C Virus Infection: Characterization in Relation to Antiphospholipid Syndrome. Clinical and Diagnostic Laboratory Immunology. 7(2). 241–244. 66 indexed citations
14.
Campins, Magda, et al.. (1994). [Infection with hepatitis B and C viruses in the mentally retarded].. PubMed. 12(3). 134–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamín López Breakdown of academic impact, for papers by Christos Koutsianas Breakdown of academic impact, for papers by Christian Folli Breakdown of academic impact, for papers by Alessio Fabbrizzi Breakdown of academic impact, for papers by Philip Ginsburg Breakdown of academic impact, for papers by F. Zhang Breakdown of academic impact, for papers by M.G. Ercilla Breakdown of academic impact, for papers by Carmen Hidalgo Breakdown of academic impact, for papers by Akiko Fujiwara Breakdown of academic impact, for papers by Shiva Prasad
Rankless by CCL
2026